Zepbound Alternatives
Zepbound is the most effective weight-loss medication currently approved, which makes "what else can I take?" a harder question than it is for other drugs. Usually the honest answer is not a different molecule at all — it is a different way of buying the same one.
First: check where you are buying it
Zepbound's list price runs from $499 to $1,086.37 per fill, but almost nobody needs to pay that. LillyDirect sells it self-pay at $299 for 2.5 mg, $399 for 5 mg and a flat $449 for every dose from 7.5 mg to 15 mg, provided you refill within 45 days.
That flat $449 at higher doses matters more than it first appears, because it is where most alternatives stop being cheaper. Amazon Pharmacy charges $499–$699 for those same doses, and compounded tirzepatide programs commonly reach $359–$545. If you are at 10 mg and paying more than $449, the cheapest alternative to Zepbound may be Zepbound.
Every alternative, compared
Zepbound via LillyDirect
Same drug, cheaper channel$299–$449/mo self-pay
Before switching, check you are buying Zepbound the cheapest way. Eli Lilly sells it direct at $299 (2.5 mg), $399 (5 mg) and a flat $449 for 7.5–15 mg with a refill within 45 days, against a list price up to $1,086 per fill.
LillyDirect review →Mounjaro (tirzepatide)
FDA-approved, same moleculeVaries by coverage and channel
Identical active ingredient from the same manufacturer, approved for type 2 diabetes rather than weight management. Which one you are prescribed depends on your diagnosis and your plan's formulary.
Providers that prescribe it →Wegovy (semaglutide)
FDA-approved, different molecule$149/mo pill, $199/mo pen via NovoCare
The main FDA-approved alternative for weight management. Average weight loss in trials is lower than tirzepatide's, but semaglutide has the stronger cardiovascular outcomes evidence from the SELECT trial — and it is cheaper.
NovoCare Pharmacy review →Wegovy pill (oral semaglutide)
FDA-approved, needle-freeFrom $149/mo; as little as $25 with commercial coverage
The cheapest FDA-approved GLP-1 route available, and no injection. A strong option if cost or needles are what is pushing you away from Zepbound.
Oral GLP-1 providers →Foundayo (orforglipron)
FDA-approved, newer oral GLP-1From $149/mo self-pay; as little as ~$25 with savings offers
Eli Lilly's small-molecule oral GLP-1, without the food and water timing restrictions of earlier oral semaglutide. A newer option worth asking about.
Oral GLP-1 providers →Compounded tirzepatide
Not FDA-approved$100–$545/mo plus any membership fee
The same molecule from a compounding pharmacy. Genuinely cheaper at low doses — Trimi charges $125 flat and Alloy's medication starts at $100 — but at 7.5 mg and above, Zepbound's flat $449 often wins on price as well as approval.
Best tirzepatide providers →Compounded semaglutide
Not FDA-approved$70–$299/mo plus any membership fee
The cheapest compounded route, with flat-price programs from $99. Not FDA-approved, and availability has been unstable since the shortage ended in February 2025.
Best compounded providers →Contrave or Saxenda
FDA-approved, non-tirzepatideVaries by provider and coverage
Relevant if tirzepatide is contraindicated or intolerable. Contrave is an oral non-GLP-1 combination; Saxenda is a daily GLP-1 injection with an approved generic liraglutide available.
Form Health review →Choosing by reason
- If cost is the problem
- Compare LillyDirect's flat $449 against whatever you pay now, then look at semaglutide — the Wegovy pill at $149/mo is the cheapest FDA-approved GLP-1 available. Compounded tirzepatide only wins at low doses.
- If supply or pharmacy access is the problem
- Zepbound is available through several channels — LillyDirect, Amazon Pharmacy, Prescryptive, Fuze Health, Gifthealth and Walmart Pharmacy, which offers retail pickup at the same self-pay price.
- If side effects are the problem
- Switching to semaglutide will not necessarily help — the two share a gastrointestinal side-effect profile. Talk to your prescriber about slowing titration or holding at an effective intermediate dose first. See managing GLP-1 side effects.
- If the injection is the problem
- There is no FDA-approved oral tirzepatide. Your needle-free options are oral semaglutide or Foundayo — see oral and needle-free providers.
- If insurance denied it
- Before switching drugs, try getting the denial overturned. Klinic and DevotedDoc both handle prior authorization on your behalf.
Frequently asked questions
Is compounded tirzepatide a good Zepbound alternative?
At low doses it can be substantially cheaper. At 7.5 mg and above the economics usually reverse, because Zepbound is a flat $449 while compounded programs price by milligrams and commonly reach $359–$545. Compounded products are also not FDA-approved, and Eli Lilly has warned it found significant levels of an impurity in certain compounded tirzepatide products containing vitamin B12.
Will switching to Wegovy mean worse results?
On average, tirzepatide produced greater weight loss than semaglutide in the SURMOUNT-5 head-to-head trial. But averages do not predict individuals, and semaglutide has stronger cardiovascular outcomes evidence from the SELECT trial — which may matter more if you have established cardiovascular disease.
What is the difference between Zepbound and Mounjaro?
They are the same active ingredient, tirzepatide, from the same manufacturer. Zepbound is approved for chronic weight management and obstructive sleep apnea in adults with obesity; Mounjaro is approved for type 2 diabetes.
Do I have to buy needles separately?
With LillyDirect, yes — Lilly states pen needles are a separate purchase for the KwikPen, and needles and syringes are separate for vials. Most compounded programs include an injection kit.
Where to go next
Medical disclaimer
This article is general information, not medical advice, and it is not a recommendation to switch or stop any medication. Only a licensed healthcare professional who knows your medical history can decide which treatment is appropriate for you. GLP-1 medications carry a boxed warning regarding thyroid C-cell tumors and other serious potential risks. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Pricing changes frequently — verify current rates directly.
Date reviewed: August 3, 2026